AMPH - Amphastar Pharmaceuticals, Inc.
IEX Last Trade
37.985
-0.100 -0.263%
Share volume: 8,211
Last Updated: Thu 26 Dec 2024 08:29:48 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$38.08
-0.10
-0.26%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-10 | 2022-08-09 | 2022-11-08 | 2023-03-01 | 2023-05-09 | 2023-08-09 | 2023-11-08 | 2024-02-29 | |
| Total revenue | 120.368 M | 123.467 M | 120.129 M | 135.023 M | 140.022 M | 145.712 M | 180.556 M | 178.105 M | |
| Cost of revenue | 64.542 M | 60.111 M | 61.619 M | 63.855 M | 66.182 M | 72.974 M | 72.153 M | 81.965 M | |
| Gross profit | 55.826 M | 63.356 M | 58.510 M | 71.168 M | 73.840 M | 72.738 M | 108.403 M | 96.140 M | |
| 13.49% | -7.65% | 21.63% | 3.75% | -1.49% | 49.03% | -11.31% | |||
| Operating expenses | 34.212 M | 38.533 M | 35.282 M | 33.336 M | 40.407 M | 35.842 M | 35.725 M | 42.160 M | |
| Selling general and admin | 17.989 M | 15.735 M | 16.768 M | 16.100 M | 20.592 M | 18.999 M | 19.061 M | 21.741 M | |
| Research and development | 16.223 M | 22.798 M | 18.514 M | 17.236 M | 19.815 M | 16.843 M | 16.664 M | 20.419 M | |
| Total expenses | 98.754 M | 98.644 M | 96.901 M | 97.191 M | 106.589 M | 108.816 M | 107.878 M | 124.125 M | |
| -0.11% | -1.77% | 0.30% | 9.67% | 2.09% | -0.86% | 15.06% | |||
| Operating income | 21.614 M | 24.823 M | 23.228 M | 37.832 M | 33.433 M | 36.896 M | 72.678 M | 53.980 M | |
| Ebit | 20.911 M | 24.569 M | 23.065 M | 37.775 M | 32.648 M | 36.595 M | 72.288 M | 53.475 M | |
| Pretax income | 28.330 M | 22.897 M | 22.433 M | 41.203 M | 32.784 M | 32.507 M | 63.247 M | 40.840 M | |
| -19.18% | -2.03% | 83.67% | -20.43% | -0.84% | 94.56% | -35.43% | |||
| Income tax | 4.077 M | 5.551 M | 6.559 M | 7.290 M | 6.752 M | 6.383 M | 14.025 M | 4.673 M | |
| Net income basic | 24.253 M | 17.346 M | 15.874 M | 33.913 M | 26.032 M | 26.124 M | 49.222 M | 36.167 M | |
| -28.48% | -8.49% | 113.64% | -23.24% | 0.35% | 88.42% | -26.52% | |||
| Net income | 24.253 M | 17.346 M | 15.874 M | 33.913 M | 26.032 M | 26.124 M | 49.222 M | 36.167 M | |
| -28.48% | -8.49% | 113.64% | -23.24% | 0.35% | 88.42% | -26.52% |